deltatrials
Completed PHASE2 INTERVENTIONAL 9-arm NCT03201419

A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults

A Randomised, Double-blind, Placebo-controlled, Response-adaptive Dose-finding Trial Investigating the Efficacy, Safety and Tolerability of Oral Doses of FE 201836, With Desmopressin Orally Disintegrating Tablet as a Benchmark, During 12 Weeks of Treatment for Nocturia Due to Nocturnal Polyuria in Adults

Sponsor: Ferring Pharmaceuticals

Conditions Nocturia
Interventions Desmopressin FE 201836 Placebo ODT Placebo oral solution
Updated 31 times since 2017 Last updated: Feb 17, 2022 Started: Jul 27, 2017 Primary completion: Oct 31, 2019 Completion: Oct 31, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03201419, this PHASE2 trial focuses on Nocturia and remains completed. Sponsored by Ferring Pharmaceuticals, it has been updated 31 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jul 2017 – ~Aug 2017 · 31 days · monthly snapshot~Aug 2017 – ~Sep 2017 · 31 days · monthly snapshot~Sep 2017 – ~Oct 2017 · 30 days · monthly snapshot~Oct 2017 – ~Nov 2017 · 31 days · monthly snapshot~Nov 2017 – ~Dec 2017 · 30 days · monthly snapshot~Dec 2017 – ~Jan 2018 · 31 days · monthly snapshot~Jan 2018 – ~Feb 2018 · 31 days · monthly snapshot~Feb 2018 – ~Apr 2018 · 59 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Feb 2019 · 2 months · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~Jul 2019 · 3 months · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Dec 2019 · 3 months · monthly snapshot~Dec 2019 – ~Jul 2020 · 7 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Apr 2022 · 4 months · monthly snapshot~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

31 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Apr 2022 — Jul 2024 [monthly]

    Completed PHASE2

  5. Dec 2021 — Apr 2022 [monthly]

    Completed PHASE2

▶ Show 26 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE2

  2. Jul 2020 — Jan 2021 [monthly]

    Completed PHASE2

  3. Dec 2019 — Jul 2020 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  4. Sep 2019 — Dec 2019 [monthly]

    Active Not Recruiting PHASE2

  5. Aug 2019 — Sep 2019 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  6. Jul 2019 — Aug 2019 [monthly]

    Recruiting PHASE2

  7. Apr 2019 — Jul 2019 [monthly]

    Recruiting PHASE2

  8. Mar 2019 — Apr 2019 [monthly]

    Recruiting PHASE2

  9. Feb 2019 — Mar 2019 [monthly]

    Recruiting PHASE2

  10. Dec 2018 — Feb 2019 [monthly]

    Recruiting PHASE2

  11. Nov 2018 — Dec 2018 [monthly]

    Recruiting PHASE2

  12. Oct 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  13. Sep 2018 — Oct 2018 [monthly]

    Recruiting PHASE2

  14. Aug 2018 — Sep 2018 [monthly]

    Recruiting PHASE2

  15. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE2

  16. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE2

  17. May 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

  18. Apr 2018 — May 2018 [monthly]

    Recruiting PHASE2

  19. Feb 2018 — Apr 2018 [monthly]

    Recruiting PHASE2

  20. Jan 2018 — Feb 2018 [monthly]

    Recruiting PHASE2

  21. Dec 2017 — Jan 2018 [monthly]

    Recruiting PHASE2

  22. Nov 2017 — Dec 2017 [monthly]

    Recruiting PHASE2

    Status: Active Not Recruiting → Recruiting

  23. Oct 2017 — Nov 2017 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  24. Sep 2017 — Oct 2017 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  25. Aug 2017 — Sep 2017 [monthly]

    Not Yet Recruiting PHASE2

  26. Jul 2017 — Aug 2017 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ferring Pharmaceuticals
Data source: Ferring Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aventura, United States , Avon, United States , Benešov, Czechia , Birmingham, United States , Brno, Czechia , Brussels, Belgium , Budapest, Hungary , Bydgoszcz, Poland , Charlotte, United States , Clearwater, United States and 54 more locations